Thomas Lytle

Sought after by clients and colleagues alike for his ability to find clarity through complexity, Tom is passionate about helping teams maximize the meaning and impact of their work, while simultaneously improving the overall consumer experience. Mr. Lytle has more than 25 years of business experience working in the finance, technology, and healthcare space.   He is the founder and managing director of Succession Capital USA, which he formed to help small business entrepreneurs innovate, grow, and realize an optimal exit strategy.

Prior to founding Succession Capital USA, Mr. Lytle was recruited to join R1's finance team to help them prepare to go public by improving operating margins. He spent 15 years at R1 in increasing responsibility roles and is most proud of the following achievements:

• Bringing the firm IPO: (NYSE on May 20, 2010 and NASDAQ on March 20, 2018)
• Winning R1's innovation tournament (#1 out of 1,350 entries) and implementing the idea
• Leading operational due diligence workstreams on three completed acquisitions
• Managing various enterprise c-level client relationships
• Leading R1's Digital Transformation Office,
• Preparing board, investor, and client presentations, and
• Optimizing various revenue cycle processes including the consumer experience

Mr. Lytle's superpowers include, but are not limited to, general problem solving, crafting business strategy, delivering margin expansion and growth, optimizing operational processes, M&A, due diligence, contracting, and negotiations.

Tom has set strategy and delivered results for some of the world's foremost firms, including Ascension Health, Intermountain Healthcare, Sutter Health, LifePoint Health, Quorum Health, HCA Healthcare, VeriSign, Symantec, NTT Data, Netrex Systems, Telenisus, INEOS Phenol, Google, ESI, Coca Cola Enterprises, and many more.